Evidence map›Paper›PMID 36680240›Full record

ArticleViruses2023

Polymycovirus Infection Sensitizes

Gabriele Sass, Ioly Kotta-Loizou, Marife Martinez, David J Larwood, David A Stevens

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. The Expanding Mycovirome ofJournal of fungi (Basel, Switzerland) · 2024
    Review
  12. AfuPmV-1-InfectedJournal of fungi (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Gabriele SassCalifornia Institute for Medical Research, San Jose, CA 95128, USA.
Ioly Kotta-LoizouDepartment of Life Sciences, Faculty of Natural Sciences, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.ORCID 0000-0003-3277-6359
Marife MartinezCalifornia Institute for Medical Research, San Jose, CA 95128, USA.
David J LarwoodValley Fever Solutions, Tucson, AZ 85719, USA.ORCID 0000-0001-8202-0483
David A StevensCalifornia Institute for Medical Research, San Jose, CA 95128, USA.
California Institute for Medical Research · USUniversity of Hertfordshire · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection with Aspergillus fumigatus polymycovirus 1 (AfuPmV-1) weakens resistance of

Indexed as

Antifungal AgentsRNA VirusesAminoglycosidesAmphotericin BAspergillus fumigatusAminoglycosidesAmphotericin BAntifungal Agentsnikkomycinantifungal drugsAspergillus fumigatusbiofilmnikkomycin Zpolymycovirustherapy

Identifiers

PMID36680240
PMCPMC9864188
OpenAlexW4315498840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.